RF-5301 Fluorescence Spectrophotometer from Shimadzu
...riments often call for critical, but time-consumin...ion Agent refines siRNA transfection protocols res...ased formulation can be used to efficiently transf...t increased cytotoxicity. From start to finish, su...
DTT; 1,4-Dithiothreitol from Roche Applied Science
...d Tissue Staining Kits are intended for localizati...d cytological specimens. These kits may be used wi...&D Systems or by other vendors. Briefly, detection...mplex (ABC) with primary antibodies that reacted w...
Biology Products:...review of published data on use of human growth ho...e synthetic hormone was associated with small chan...other clinically important outcomes. , Further, p... side effects such as soft tissue swelling, joint ...l breast development. They were also somewhat mor...
... international research team has found evidence of...5 million years. , Upright stumps of fossilised tr...upstate New York, more than a century ago. However...s looked like. , Two years ago, two fossils wer...ways, with their trunk, branches, twigs and crown ...
...method of mass-producing disease-fighting antibodi...a research group at The University of Texas at Aus...oped the new antibody-production approach to impro...drugs. Drug companies have used those more time- ...s for treating rheumatoid arthritis, cancer and ot...
Other Biology News:Growth hormone is not the anti-aging bullet for healthy adults 2Growth hormone is not the anti-aging bullet for healthy adults 3Cheaper, better disease treatments expected from faster approach to developing antibodies 2(Date:11/30/2009)...S ANGELES, Nov. 30 /PRNewswire-Asia-FirstCall/ --,...Board: CYXN; ,China Yongxin,Pharmaceuticals, or ,t...and,retailer of pharmaceuticals in Northeastern Ch...for distribution of medicines on the Essential Dru... formalized the nation,s Essential Drug,List which...
(Date:11/30/2009)...wire-FirstCall/ -- BioMarin Pharmaceutical Inc. (N...rug Administration (FDA) has granted orphan drug d...ampridine phosphate, for the rare autoimmune disea...DAP has previously received orphan drug designatio...e for Medicinal Products for Human Use of the Euro...
(Date:11/30/2009)...wire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (... class of platinum-based anti-tumor compounds, ter...umor potency and activity compared to currently av...ility to overcome cisplatin-resistance in cancer c...titled "Novel Bis-platinum Complexes Endowed with ...
(Date:11/30/2009)...Newswire-Asia/ -- WuXi PharmaTech (NYSE: WX ), a...l-device research and,development outsourcing comp...,announced that it had been selected to the Deloi...th consecutive year. The list recognizes the 50,fa...ia, and telecommunications,industries based on rev...
Breaking Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2